NCT00737529 · Interventional trial
A Study to Determine the Efficacy and Safety of Lenalidomide in Patients With Mantle Cell NHL Who Have Relapsed or Progressed After Treatment With Bortezomib or Are Refractory to Bortezomib. The "EMERGE" Trial
Overall registry status Completed
Phase 2
Conditions Mantle Cell Lymphoma
Delaware Valley sites
- Temple University School of Medicine · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory